PN Medical CEO discusses The Breather, a drug-free device that helps patients manage a variety of respiratory complications. Allergy season (unfortunately) is in full swing. Tree pollen typically pops up in early to late March and climate change ... Quitting smoking is among the top New Year's resolutions for 2023, but as statistics show, most people have trouble ... DocWire News recently spoke with Chris Ambrose, MD, MBA, Franchise Head, US BioPharmaceuticals Medical, Respiratory at ... DocWire News recently spoke with Frank Trudo, MD, Vice President, US Medical, Respiratory and Immunology at ... Earlier this month, the New England Journal of Medicine released Phase 3 clinical trial results for tezepelumab - a ... In a recent interview, Michael Peters, MD, MAS, assistant professor at the University of California, San Francisco ... Greg Duncan, CEO of Celtaxsys discussed cystic fibrosis (CF) and the role of pulmonary exacerbations. Celtaxsys recently ... Greg Duncan, CEO of Celtaxsys discusses the top line results of the company's Phase 2 EMPIRE-CF trial evaluating oral, ...